Gardiquimod

• Target:

  HIV Protease|||TLR

• Related Pathways:

  Microbiology/Virology|||Proteases/Proteasome|||Immunology/Inflammation

• Purity:

  0.9968

• Bioactivity:

  Gardiquimod could inhibit HIV-1 infection of macrophages and activated peripheral blood mononuclear cells. Gardiquimod is an imidazoquinoline analog and is a TLR7/8 agonist. When used at concentrations below 10??M, Gardiquimod specifically activates TLR7.

• Smiles:

  CCNCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O

• Molecular Formula:

  C17H23N5O

• Molecular Weight:

  313.4

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1020412-43-4